Boston Micro Fabrication (BMF), a complicated manufacturing options for ultra-high precision functions supplier, has reportedly achieved a 30% development in gross sales in 2023. BMF additionally secured $23 million in Sequence D funding, launched in new markets, and expanded its San Diego Analysis Institute (SDRI) – rising to 200+ staff members and serving greater than 1,800 firms worldwide.
BMF’s development is grounded in its distinctive, excessive precision and micro decision 3D printing know-how – Projection Micro Stereolithography (PμSL) – which leverages mild, customizable optics, a high-quality motion platform, and managed processing know-how to provide the best precision on the 2μm scale. The corporate is targeted on figuring out distinctive functions for this know-how utilizing new supplies similar to BMF MED and Mechnano’s Formula1µ to assist propel innovation throughout industries.
“Amid a difficult financial surroundings on each a worldwide stage and for the 3D printing trade, we’re very happy with the progress made during the last 12 months to assist our clients push the boundaries on what is feasible with our know-how. And whereas a whole lot of this success is because of sturdy execution from our staff, a lot of it’s primarily based on our product-market focus and the truth that we’re constructing a high-value, differentiated enterprise,” stated John Kawola, CEO of Boston Micro Fabrication.
Entry into dental markets: Ultrathineer
In 2023, BMF entered the dental market with the launch of Ultrathineer, the world’s thinnest beauty dental veneers. Beauty veneers are presently pressed or milled, and intrusive preparation and grinding are often required to make sure a superb match. With Ultrathineer, this grinding is minimized or eradicated – creating a greater expertise for sufferers with much less time-intensive procedures for dentists.
This product is a part of the corporate’s technique to determine and develop high-value functions the place its know-how platform can add distinctive worth. Testing and improvement have been going properly, with clearance from the US Meals and Drug Administration (FDA) anticipated by mid-2024.
“Small components requiring very excessive ranges of precision are troublesome to prototype and manufacture, and we’re persevering with to deal with segments of the manufacturing and design market that might not be attainable via different strategies,” stated Kawola. “3D printing is a robust software right here, and we’re persevering with to uncover new functions for our know-how.”
San Diego Analysis Institute
In 2023, BMF additionally started analysis at its San Diego Analysis Institute, a brand new analysis and improvement middle in San Diego, California, that has been shaped particularly to develop and incubate end-product concepts which might be uniquely enabled by BMF’s micro-3D manufacturing platform.
The primary initiative underway is the event of next-generation lab-on-chip constructions that leverage the distinctive benefits of micro-3D printing for cell and tissue cultures. Whereas the idea of a lab-on-a-chip was first launched over 20 years in the past, this new chip introduces a vascularized platform for drug discovery and beauty testing. SDRI goals to revolutionize these industries via its ongoing analysis and improvement of latest manufacturing strategies and superior capabilities for these constructions.